
1. Reduce risk
Screen out weak-fit solutions before capital is committed.
Avoided loss: fewer failed deployments, fewer hidden-cost contracts, lower remediation risk.
2. Improve decisions
Align clinical, IT, compliance, operations, and finance around one evidence base.
Growth & value: faster confident decisions and stronger realization of clinical and operational benefits.
3. Preserve value
Monitor performance, equity, and vendor accountability after go-live.
Sustainability: governance assets that support future procurements at lower marginal effort.


CAHIR translates complex procurement questions into a structured, weighted decision model with measurable benefits that can be harnessed across industry. We provide in-depth expertise for Phase 3 of the advisory system: comprehensive evaluation and scoring. Our evaluation approach uses a weighted scoring model across 3 domains with clear and user-friendly scoring rubrics. Domain scores are weighted and combined into a composite Procurement Readiness Score (PRS).
PRS Interpretation: 85–100 = Recommended for Procurement | 70–84 = Conditional Approval (address gaps) | 55–69 = Hold — Significant Remediation Required | Below 55 = Do Not Procure
